Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14633962 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment
Conditions: Hepatitis;   Tuberculosis;   hepatitisB
Intervention: Drug: entecavir (BARACLUDE®)

Indicates status has not been verified in more than two years